Sfoglia per Rivista  ONCOTARGET

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 1 a 20 di 46
Titolo Data di pubblicazione Autori File
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer 1-gen-2014 GENERALI, DANIELE +
The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway 1-gen-2015 RIMONDI, Erika +
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer 1-gen-2018 Roviello, GiandomenicoCorona, Silvia PaolaGenerali, Daniele +
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 1-gen-2016 Baldassarre, GustavoCanzonieri, Vincenzo +
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer 1-gen-2017 Rocca, Andrea +
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 1-gen-2016 COMAR, ManolaBOVENZI, MASSIMO +
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a nonendemic area 1-gen-2017 Marceglia, SaraLasorsa, IreneBossi, Paolo +
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study 1-gen-2018 Generali, Daniele +
Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study 1-gen-2017 GENERALI, DANIELE +
Emx2 as a novel tool to suppress glioblastoma 1-gen-2016 LEANZA, Giampiero +
Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells 1-gen-2017 Dinami, RBuemi, VZappone, ACiani, YPetti, EGiacca, MSchoeftner, S +
Epithelioid peritoneal mesothelioma: A hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework 1-gen-2016 BRICH, SILVIA +
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 1-gen-2018 D'ANCONA, CRISTINAGenerali, Daniele +
HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness 1-gen-2013 PEGORARO, SILVIAROS, GLORIACIANI, YARISGARRA, RICCARDODEL SAL, GIANNINOMANFIOLETTI, GUIDALBERTO +
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 1-gen-2017 MACOR, PAOLOSBLATTERO, DANIELE +
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer 1-gen-2017 Corona, Silvia PaolaGenerali, DanieleRoviello, Giandomenico +
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 1-gen-2016 RIMONDI, ErikaCELEGHINI, CLAUDIO +
Identification of a gene expression driven progression pathway in Myxoid liposarcoma 1-gen-2014 BRICH, SILVIA +
Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy 1-gen-2017 Canzonieri, VincenzoCannizzaro, Renato +
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: A retrospective exploratory analysis of the BALLET study 1-gen-2020 Corona, SGiudici, FBernocchi, OGenerali, D +
Mostrati risultati da 1 a 20 di 46
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile